RAC 7.03% $1.52 race oncology ltd

Ann: Expanded Heart Protection Discovery for Zantrene, page-92

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 54 Posts.
    lightbulb Created with Sketch. 6
    So what your basically saying is RAC has Amgen by the balls. If Amgen lose Carfilzomib sole distribution rights in 2025 they will lose a lot of income. RAC has the upper hand in negotiations which is good news for shareholders.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.52
Change
-0.115(7.03%)
Mkt cap ! $259.1M
Open High Low Value Volume
$1.62 $1.63 $1.52 $167.4K 104.8K

Buyers (Bids)

No. Vol. Price($)
1 2239 $1.52
 

Sellers (Offers)

Price($) Vol. No.
$1.60 391 1
View Market Depth
Last trade - 16.10pm 07/11/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.